Download presentation
Presentation is loading. Please wait.
Published byAugustus Hunter Modified over 5 years ago
1
Outpatient Uterine Artery Embolization for Symptomatic Fibroids: Short- and Long-Term Single Institution-Based Outcomes Pasteur Rasuli, MD, FRCPC, Armin Sabri, MD, Ian Hammond, MD, FRCPC, Gordon J. French, MD, FRCPC, Nathalie Gamache, MD, FRCSC, Elaine E. Jolly, MD, FRCSC Journal of Obstetrics and Gynaecology Canada Volume 35, Issue 2, Pages (February 2013) DOI: /S (15) Copyright © 2013 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
2
Figure 1 AP radiograph shows transperitoneal placement of a 15cm Chiba needle and injection of contrast medium confirming the satisfactory retroperitoneal and extravascular position of the needle tip inferior to the aortic bifurcation (long arrow) as depicted by the position of the IA catheter (arrowheads) before the injection of bupivicaine to produce a superior hypogastric nerve block Journal of Obstetrics and Gynaecology Canada , DOI: ( /S (15) ) Copyright © 2013 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
3
Figure 2 Distribution of pain intensity at different phases of post-UAE recovery Journal of Obstetrics and Gynaecology Canada , DOI: ( /S (15) ) Copyright © 2013 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
4
Figure 3 Prevalence of various post-UAE side effects
Journal of Obstetrics and Gynaecology Canada , DOI: ( /S (15) ) Copyright © 2013 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
5
Figure 4 Status of resumed menses following UAE
Journal of Obstetrics and Gynaecology Canada , DOI: ( /S (15) ) Copyright © 2013 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
6
Figure 5 Overall patient satisfaction rate with the treatment
Journal of Obstetrics and Gynaecology Canada , DOI: ( /S (15) ) Copyright © 2013 Society of Obstetricians and Gynaecologists of Canada Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.